Cerus Corp. (CERS)
1.855
-0.13
(-6.55%)
USD |
NASDAQ |
Nov 16, 16:00
1.855
0.00 (0.00%)
After-Hours: 18:50
Cerus Total Assets (Quarterly) : 204.73M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 204.73M |
| June 30, 2026 | 205.19M |
| March 31, 2026 | 222.91M |
| December 31, 2025 | 221.86M |
| September 30, 2025 | 215.18M |
| June 30, 2025 | 213.07M |
| March 31, 2025 | 206.78M |
| December 31, 2024 | 200.92M |
| September 30, 2024 | 189.54M |
| June 30, 2024 | 185.50M |
| March 31, 2024 | 189.14M |
| December 31, 2023 | 197.75M |
| September 30, 2023 | 205.84M |
| June 30, 2023 | 198.86M |
| March 31, 2023 | 209.34M |
| December 31, 2022 | 218.09M |
| September 30, 2022 | 215.40M |
| June 30, 2022 | 216.46M |
| March 31, 2022 | 221.91M |
| December 31, 2021 | 237.50M |
| September 30, 2021 | 218.95M |
| June 30, 2021 | 223.22M |
| March 31, 2021 | 220.58M |
| December 31, 2020 | 221.42M |
| September 30, 2020 | 213.35M |
| Date | Value |
|---|---|
| June 30, 2020 | 215.49M |
| March 31, 2020 | 215.36M |
| December 31, 2019 | 165.54M |
| September 30, 2019 | 164.44M |
| June 30, 2019 | 174.63M |
| March 31, 2019 | 175.93M |
| December 31, 2018 | 163.46M |
| September 30, 2018 | 161.66M |
| June 30, 2018 | 151.85M |
| March 31, 2018 | 144.42M |
| December 31, 2017 | 98.24M |
| September 30, 2017 | 97.09M |
| June 30, 2017 | 83.48M |
| March 31, 2017 | 84.94M |
| December 31, 2016 | 103.48M |
| September 30, 2016 | 116.12M |
| June 30, 2016 | 120.45M |
| March 31, 2016 | 127.94M |
| December 31, 2015 | 139.40M |
| September 30, 2015 | 135.19M |
| June 30, 2015 | 151.41M |
| March 31, 2015 | 143.22M |
| December 31, 2014 | 81.78M |
| September 30, 2014 | 79.40M |
| June 30, 2014 | 76.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 108.25B |
| AngioDynamics, Inc. | 241.93M |
| Alphatec Holdings, Inc. | 796.74M |
| AtriCure, Inc. | 717.54M |
| Baxter International, Inc. | 19.41B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 128.37M |
| Shareholders Equity (Quarterly) | 75.70M |
| Debt to Equity Ratio | 0.9902 |
| Current Ratio | 1.957 |
| Net Debt Paydown Yield | 1.00% |